Integrated Filing — IndAS



General information about company

Scrip Code 500214
NSE Symbol IONEXCHANG
MSEI Symbol NOTLISTED
ISIN INE570A01022
Name of company Ion Exchange (India) Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 04-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 30-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 04-11-2025   11:30:00
End date and time of board meeting 04-11-2025   19:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 73,394.00 1,31,713.00
Other income 1,426.00 3,200.00
Total income 74,820.00 1,34,913.00
2 Expenses
(a) Cost of materials consumed 45,294.00 77,135.00
(b) Purchases of stock-in-trade 3,523.00 6,472.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (2,880.00) (3,312.00)
(d) Employee benefit expense 9,859.00 19,472.00
(e) Finance costs 308.00 564.00
(f) Depreciation, depletion and amortisation expense 1,217.00 2,443.00
(f) Other Expenses
1 Other Expenses 10,749.00 18,843.00
Total other expenses 10,749.00 18,843.00
Total expenses 68,070.00 1,21,617.00
3 Total profit before exceptional items and tax 6,750.00 13,296.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 6,750.00 13,296.00
6 Tax expense
7 Current tax 1,733.00 3,335.00
8 Deferred tax 61.00 207.00
9 Total tax expenses 1,794.00 3,542.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 4,956.00 9,754.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 36.00 82.00
16 Total profit (loss) for period 4,992.00 9,836.00
17 Other comprehensive income net of taxes 268.00 477.00
18 Total Comprehensive Income for the period 5,260.00 10,313.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 4,953.00 9,823.00
Total profit or loss, attributable to non-controlling interests 39.00 13.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 5,177.00 10,253.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 83.00 60.00
21 Details of equity share capital
Paid-up equity share capital 1,423.00 1,423.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 4.18 8.29
Diluted earnings (loss) per share from continuing operations 4.18 8.29
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 4.18 8.29
Diluted earnings (loss) per share from continuing and discontinued operations 4.18 8.29
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: 1)The above unaudited consolidated financial results include the results of its subsidiaries - Aqua Investments (India) Limited, Ion Exchange And Company LLC, Ion Exchange Arabia for Water, Ion Exchange Asia Pacific Pte. Ltd. (Consolidated), Ion Exchange Enviro Farms Limited (IEEFL), Ion Exchange Environment Management (BD) Limited, Ion Exchange Europe LDA, Ion Exchange LLC, Ion Exchange Projects And Engineering Limited, Ion Exchange Purified Drinking Water Private Limited, Ion Exchange Safic Pty. Limited, Ion Exchange WTS (Bangladesh) Limited, Mapril - Produtos Químicos e Máquinas Para A Industria LDA, Total Water Management Services (India) Limited, Watercare Investments (India) Limited, and also includes share of profit / (loss) of its associates - Aquanomics Systems Limited, Ion Exchange Financial Products Private Limited, Ion Exchange PSS Co. Limited. 2) The above unaudited consolidated financial results which are published in accordance with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') have been reviewed by the Audit Committee at their meeting held on 4th November 2025 and approved by the Board of Directors at their meeting held on 4th November 2025. The financial results are prepared in accordance with the Ind AS prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India. 3) Earnings per equity share includes Ind AS impact of consolidation of 23,689,390 equity shares of INR 1 each and 46,750 equity shares of INR 1 each held by IEI Shareholding (Staff Welfare) Trusts and HMIL Shareholding (Staff Welfare) Trusts respectively. 4) Cost of material consumed includes direct expenses incurred on contracts: a) INR 2,221 Lacs for the quarter ended 30th September 2025, INR 1,943 Lacs for the quarter ended 30th June 2025 and INR 2,949 Lacs for the quarter ended 30th September 2024 b) INR 4,164 Lacs for half year ended 30th September 2025 and INR 4,414 Lacs for half year ended 30th September 2024 c) INR 8,864 Lacs for the year ended 31st March 2025. 5) With respect to the ongoing matter with SEBI of IEEFL (a subsidiary of the Company), the Company’s appeal filed in Supreme Court came up for hearing on 6th December 2021. The Court considered report of SEBI empaneled Auditor who was appointed by IEEFL. After detailed hearing, Supreme Court while disposing off the matter, granted liberty to IEEFL to approach SEBI requesting to reconsider the matter by producing additional material, which has been duly complied. SEBI has thereafter appointed Auditors to submit report thereon. Auditors have submitted their report to SEBI. Based on the report SEBI sought certain clarifications and IEEFL has provided clarifications in the matter. SEBI vide letter dated 16th May 2024 has directed IEEFL to deposit an amount of INR 2,202 Lacs towards repayment of money to the Investors. IEEFL has represented to SEBI to reconsider the matter in line with the Audit findings. SEBI vide email dated 7th August 2024 rejected company’s request. Company has filed appeal with SAT which came up for hearing on 17th October 2024. In the hearing the counsel for SEBI made a statement that SEBI will not initiate any recovery proceedings till the next date of hearing. SEBI filed its reply and IEEFL has filed its rejoinder. The matter will come up for hearing on 20th January 2026. IEEFL does not envisage any liability on this account. The auditors of the IEEFL has included an 'Emphasis of matter' in their review report on this account.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 61,508.00
Capital work-in-progress 20,276.00
Investment property
Goodwill 1,021.00
Other intangible assets 1,362.00
Intangible assets under development 90.00
Biological assets other than bearer plants
Investments accounted for using equity method 761.00
Non-current financial assets
Non-current investments 616.00
Trade receivables, non-current 62.00
Loans, non-current 0.00
Other non-current financial assets 1,675.00
Total non-current financial assets 2,353.00
Deferred tax assets (net) 540.00
Other non-current assets 4,895.00
Total non-current assets 92,806.00
2 Current assets
Inventories 38,614.00
Current financial asset
Current investments 57.00
Trade receivables, current 1,04,463.00
Cash and cash equivalents 20,452.00
Bank balance other than cash and cash equivalents 18,563.00
Loans, current 1,036.00
Other current financial assets 828.00
Total current financial assets 1,45,399.00
Current tax assets (net) 63.00
Other current assets 34,167.00
Total current assets 2,18,243.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 3,11,049.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,423.00
Other equity 1,27,839.00
Total equity attributable to owners of parent 1,29,262.00
Non controlling interest 221.00
Total equity 1,29,483.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 34,626.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 2,565.00
Total non-current financial liabilities 37,191.00
Provisions, non-current 2,477.00
Deferred tax liabilities (net) 884.00
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 40,552.00
Current liabilities
Current financial liabilities
Borrowings, current 5,455.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 7,689.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 65,119.00
Total Trade payable 72,808.00
Other current financial liabilities 8,628.00
Total current financial liabilities 86,891.00
Other current liabilities 51,952.00
Provisions, current 1,056.00
Current tax liabilities (Net) 1,115.00
Deferred government grants, Current
Total current liabilities 1,41,014.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1,81,566.00
Total equity and liabilites 3,11,049.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Engineering 45,620.00 77,415.00
2 Chemicals 21,840.00 40,730.00
3 Consumer Products 8,579.00 17,601.00
4 Others 0.00 0.00
5 Unallocated 0.00 0.00
Total Segment Revenue 76,039.00 1,35,746.00
Less: Inter segment revenue 2,645.00 4,033.00
Revenue from operations 73,394.00 1,31,713.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Engineering 2,238.00 5,014.00
2 Chemicals 5,908.00 10,578.00
3 Consumer Products (267.00) (360.00)
4 Others 2.00 2.00
5 Unallocated 0.00 0.00
Total Profit before tax 7,881.00 15,234.00
i. Finance cost 308.00 564.00
ii. Other Unallocable Expenditure net off Unallocable income 823.00 1,374.00
Profit before tax 6,750.00 13,296.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Engineering 1,74,890.00 1,74,890.00
2 Chemicals 1,04,594.00 1,04,594.00
3 Consumer Products 12,529.00 12,529.00
4 Others 1,693.00 1,693.00
5 Unallocated 17,343.00 17,343.00
Total Segment Asset 3,11,049.00 3,11,049.00
Un-allocable Assets 0.00 0.00
Net Segment Asset 3,11,049.00 3,11,049.00
4 Segment Liabilities
Segment Liabilities
1 Engineering 97,128.00 97,128.00
2 Chemicals 65,929.00 65,929.00
3 Consumer Products 10,094.00 10,094.00
4 Others 177.00 177.00
5 Unallocated 8,238.00 8,238.00
Total Segment Liabilities 1,81,566.00 1,81,566.00
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 1,81,566.00 1,81,566.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement benefit of defined benefit plans (3.00) (6.00)
2 Share of Other Comprehensive Income in associates 2.00 (5.00)
Total Amount of items that will not be reclassified to profit and loss (1.00) (11.00)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 (1.00)
3 Amount of items that will be reclassified to profit and loss
1 Movement in foreign currency translation reserve 269.00 487.00
Total Amount of items that will be reclassified to profit and loss 269.00 487.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 268.00 477.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 13,296.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 564.00
Adjustments for decrease (increase) in inventories (8,715.00)
Adjustments for decrease (increase) in trade receivables, current 8,837.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (7,936.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (93.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (5,455.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (46.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,443.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 669.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 631.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (700.00)
Adjustments for dividend income 15.00
Adjustments for interest income 1,250.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (16.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 254.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (10,828.00)
Net cash flows from (used in) operations 2,468.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 3,294.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (826.00)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 201.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 23.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 15,639.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 15.00
Interest received 1,709.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 13,123.00
Net cash flows from (used in) investing activities (1,016.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 9,904.00
Repayments of borrowings 170.00
Payments of lease liabilities 418.00
Dividends paid 1,778.00
Interest paid 487.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 46.00
Net cash flows from (used in) financing activities 7,097.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 5,255.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 268.00
Net increase (decrease) in cash and cash equivalents 5,523.00
Cash and cash equivalents cash flow statement at beginning of period 14,929.00
Cash and cash equivalents cash flow statement at end of period 20,452.00